S&P 500   3,149.13 (+1.02%)
DOW   28,018.94 (+1.23%)
QQQ   204.98 (+1.26%)
AAPL   270.07 (+1.69%)
FB   201.00 (+0.82%)
GOOGL   1,341.46 (+1.71%)
CGC   18.61 (+0.05%)
NVDA   212.42 (+1.43%)
MU   48.03 (+3.02%)
BABA   201.92 (+0.96%)
GE   10.99 (+1.85%)
AMD   39.76 (+0.18%)
ACB   2.43 (-0.82%)
F   9.03 (+1.12%)
NFLX   307.64 (+1.09%)
BAC   33.77 (+2.05%)
DIS   147.93 (+0.33%)
S&P 500   3,149.13 (+1.02%)
DOW   28,018.94 (+1.23%)
QQQ   204.98 (+1.26%)
AAPL   270.07 (+1.69%)
FB   201.00 (+0.82%)
GOOGL   1,341.46 (+1.71%)
CGC   18.61 (+0.05%)
NVDA   212.42 (+1.43%)
MU   48.03 (+3.02%)
BABA   201.92 (+0.96%)
GE   10.99 (+1.85%)
AMD   39.76 (+0.18%)
ACB   2.43 (-0.82%)
F   9.03 (+1.12%)
NFLX   307.64 (+1.09%)
BAC   33.77 (+2.05%)
DIS   147.93 (+0.33%)
S&P 500   3,149.13 (+1.02%)
DOW   28,018.94 (+1.23%)
QQQ   204.98 (+1.26%)
AAPL   270.07 (+1.69%)
FB   201.00 (+0.82%)
GOOGL   1,341.46 (+1.71%)
CGC   18.61 (+0.05%)
NVDA   212.42 (+1.43%)
MU   48.03 (+3.02%)
BABA   201.92 (+0.96%)
GE   10.99 (+1.85%)
AMD   39.76 (+0.18%)
ACB   2.43 (-0.82%)
F   9.03 (+1.12%)
NFLX   307.64 (+1.09%)
BAC   33.77 (+2.05%)
DIS   147.93 (+0.33%)
S&P 500   3,149.13 (+1.02%)
DOW   28,018.94 (+1.23%)
QQQ   204.98 (+1.26%)
AAPL   270.07 (+1.69%)
FB   201.00 (+0.82%)
GOOGL   1,341.46 (+1.71%)
CGC   18.61 (+0.05%)
NVDA   212.42 (+1.43%)
MU   48.03 (+3.02%)
BABA   201.92 (+0.96%)
GE   10.99 (+1.85%)
AMD   39.76 (+0.18%)
ACB   2.43 (-0.82%)
F   9.03 (+1.12%)
NFLX   307.64 (+1.09%)
BAC   33.77 (+2.05%)
DIS   147.93 (+0.33%)
Log in

NYSE:CTST - CannTrust Stock Price, Forecast & News

C$0.83
+0.04 (+5.09 %)
(As of 12/6/2019 01:51 PM ET)
Today's Range
C$0.79
Now: C$0.83
C$0.85
50-Day Range
C$0.77
MA: C$1.04
C$1.35
52-Week Range
C$0.75
Now: C$0.83
C$10.17
Volume753,758 shs
Average Volume2.66 million shs
Market CapitalizationC$116.76 million
P/E RatioN/A
Dividend YieldN/A
Beta3.23
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone64-7872-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$35.22 million
Book ValueC$1.27 per share

Profitability

Net IncomeC$-10,460,000.00

Miscellaneous

Employees576
Market CapC$116.76 million
Next Earnings Date12/11/2019 (Estimated)
OptionableOptionable

Receive CTST News and Ratings via Email

Sign-up to receive the latest news and ratings for CTST and its competitors with MarketBeat's FREE daily newsletter.


CannTrust (NYSE:CTST) Frequently Asked Questions

What is CannTrust's stock symbol?

CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."

When is CannTrust's next earnings date?

CannTrust is scheduled to release their next quarterly earnings announcement on Wednesday, December 11th 2019. View Earnings Estimates for CannTrust.

What price target have analysts set for CTST?

8 brokers have issued 1-year target prices for CannTrust's stock. Their forecasts range from C$2.00 to C$7.00. On average, they expect CannTrust's stock price to reach C$4.50 in the next year. This suggests a possible upside of 444.4% from the stock's current price. View Analyst Price Targets for CannTrust.

What is the consensus analysts' recommendation for CannTrust?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CannTrust.

Has CannTrust been receiving favorable news coverage?

Media stories about CTST stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CannTrust earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for CannTrust.

Are investors shorting CannTrust?

CannTrust saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 13,640,000 shares, an increase of 15.2% from the September 30th total of 11,840,000 shares. Based on an average daily volume of 2,650,000 shares, the short-interest ratio is currently 5.1 days. Approximately 11.4% of the company's stock are short sold. View CannTrust's Current Options Chain.

Who are some of CannTrust's key competitors?

What other stocks do shareholders of CannTrust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Aurora Cannabis (ACB), Cronos Group (CRON), HEXO (HEXO), Nokia Oyj (NOK), Aphria (APHA) and OrganiGram (OGI).

Who are CannTrust's key executives?

CannTrust's management team includes the folowing people:
  • Mr. Eric Paul, Co-Founder & Chairman (Age 78)
  • Mr. Brad Rogers, Pres (Age 49)
  • Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)
  • Mr. Peter Ralph Aceto, Chief Exec. Officer
  • Mr. Greg Guyatt, Chief Financial Officer

Who are CannTrust's major shareholders?

CannTrust's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Legacy Advisors LLC (0.04%), Cambridge Investment Research Advisors Inc. (0.03%) and Virtu Financial LLC (0.02%). Company insiders that own CannTrust stock include Aubrey Dan, Financial Corporation Forum and Mark Litwin. View Institutional Ownership Trends for CannTrust.

Which institutional investors are selling CannTrust stock?

CTST stock was sold by a variety of institutional investors in the last quarter, including Legacy Advisors LLC. View Insider Buying and Selling for CannTrust.

Which institutional investors are buying CannTrust stock?

CTST stock was bought by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc. and Virtu Financial LLC. View Insider Buying and Selling for CannTrust.

How do I buy shares of CannTrust?

Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CannTrust's stock price today?

One share of CTST stock can currently be purchased for approximately C$0.83.

How big of a company is CannTrust?

CannTrust has a market capitalization of C$116.95 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe.View Additional Information About CannTrust.

What is CannTrust's official website?

The official website for CannTrust is http://www.canntrust.ca/.

How can I contact CannTrust?

CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected]


MarketBeat Community Rating for CannTrust (NYSE CTST)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  151 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  328
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CTST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Strangles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel